Skip to main content
. 2017 Sep 6;14(5):5107–5113. doi: 10.3892/ol.2017.6891

Figure 2.

Figure 2.

Coordinated carcinogenic effects of ARID1A/B. If ARID1A is mutated, the ARID1B mechanism enhances cancer development. ARID1B inhibition destabilizes the SWI/SNF complex, which leads to inhibition of cell proliferation. ARID1B, AT-rich interaction domain 1A; SWI/SNF, switch/sucrose non-fermentable complex.